Key points are not available for this paper at this time.
This study confirms that YKL-40 is expressed by a subset of astrocytes in AD and other tauopathies. YKL-40 expression is elevated in several neurodegenerative conditions and correlates with tau pathology.
Querol‐Vilaseca et al. (Fri,) studied this question.